SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000875320-22-000038
Filing Date
2022-10-28
Accepted
2022-10-28 16:07:51
Documents
80
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q vrtx-20220930.htm   iXBRL 10-Q 1767846
2 EX-31.1 a2022q310-qexhibit311.htm EX-31.1 10835
3 EX-31.2 a2022q310-qexhibit312.htm EX-31.2 10833
4 EX-32.1 a2022q310-qexhibit321.htm EX-32.1 6413
10 vrtx-20220930_g1.gif GRAPHIC 10702
  Complete submission text file 0000875320-22-000038.txt   8070872

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vrtx-20220930.xsd EX-101.SCH 41784
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT vrtx-20220930_cal.xml EX-101.CAL 84563
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vrtx-20220930_def.xml EX-101.DEF 262549
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vrtx-20220930_lab.xml EX-101.LAB 559781
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vrtx-20220930_pre.xml EX-101.PRE 402447
74 EXTRACTED XBRL INSTANCE DOCUMENT vrtx-20220930_htm.xml XML 1651820
Mailing Address 50 NORTHERN AVENUE BOSTON MA 02210
Business Address 50 NORTHERN AVENUE BOSTON MA 02210 6173416393
VERTEX PHARMACEUTICALS INC / MA (Filer) CIK: 0000875320 (see all company filings)

IRS No.: 043039129 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19319 | Film No.: 221341911
SIC: 2834 Pharmaceutical Preparations